scispace - formally typeset
Open AccessJournal ArticleDOI

The inflammatory response in sepsis.

Markus Bosmann, +1 more
- 01 Mar 2013 - 
- Vol. 34, Iss: 3, pp 129-136
Reads0
Chats0
TLDR
Recent insights into the signaling pathways in immune and phagocytic cells that underlie sepsis and SIRS are discussed and how these might be targeted for therapeutic interventions to reverse or attenuate pathways that lead to lethality during sepsi are considered.
About
This article is published in Trends in Immunology.The article was published on 2013-03-01 and is currently open access. It has received 382 citations till now. The article focuses on the topics: Systemic inflammatory response syndrome & Septic shock.

read more

Citations
More filters
Journal ArticleDOI

Niacin and Selenium Attenuate Sepsis-Induced Lung Injury by Up-Regulating Nuclear Factor Erythroid 2–Related Factor 2 Signaling*

TL;DR: The combination therapy of niacin and selenium attenuated lung injury and improved survival during sepsis and its therapeutic benefits were associated with the synergistic activation of the glutathione redox cycle, reduction of hydrogen peroxide level, and up-regulation of nuclear factor erythroid 2–related factor 2.
Journal ArticleDOI

MFHAS1 Is Associated with Sepsis and Stimulates TLR2/NF-κB Signaling Pathway Following Negative Regulation.

TL;DR: It was shown that blood MFHAS1 was significantly elevated in sepsis patients, and MFH AS1 was more increased in mononuclear cells from septic patients, as well as the effect of MFHas1 on the TLR2 signaling pathway.
Journal ArticleDOI

Macrophage-Derived Iron-Bound Lipocalin-2 Correlates with Renal Recovery Markers Following Sepsis-Induced Kidney Damage.

TL;DR: It is hypothesized that both the cellular source of Lcn-2 as well as its iron-load crucially adds to its biological function during sepsis-induced renal injury.
Journal ArticleDOI

miR-23b Negatively Regulates Sepsis-Induced Inflammatory Responses by Targeting ADAM10 in Human THP-1 Monocytes.

TL;DR: It is demonstrated that miR-23b negatively regulated LPS-induced inflammatory responses by targeting ADAM10 and may provide potential therapeutic targets for sepsis.
Journal ArticleDOI

Role of CD146 (MCAM) in Physiological and Pathological Angiogenesis-Contribution of New Antibodies for Therapy.

TL;DR: In this paper, the authors reviewed the multifaceted functions of CD146 in physiological and pathological angiogenesis and summarized the interest of using monoclonal antibodies for therapeutic purposes.
References
More filters
Journal ArticleDOI

Free radicals and antioxidants in normal physiological functions and human disease

TL;DR: Attention is focussed on the ROS/RNS-linked pathogenesis of cancer, cardiovascular disease, atherosclerosis, hypertension, ischemia/reperfusion injury, diabetes mellitus, neurodegenerative diseases, rheumatoid arthritis, and ageing.
Journal ArticleDOI

The Epidemiology of Sepsis in the United States from 1979 through 2000

TL;DR: The rate of sepsis due to fungal organisms increased by 207 percent, with gram-positive bacteria becoming the predominant pathogens after 1987, and the total in-hospital mortality rate fell, yet the total number of deaths continued to increase.
Journal ArticleDOI

The acute respiratory distress syndrome.

TL;DR: Progress has been made in understanding the mechanisms responsible for the pathogenesis and the resolution of lung injury, including the contribution of environmental and genetic factors, and on developing novel therapeutics that can facilitate and enhance lung repair.
Journal ArticleDOI

Immunodesign of experimental sepsis by cecal ligation and puncture.

TL;DR: Standardized procedures for inducing sepsis in mice and rats are defined by applying defined severity grades of sepsi through modulation of the position of cecal ligation.
Journal ArticleDOI

Immunosuppression in patients who die of sepsis and multiple organ failure.

TL;DR: Patients who die in the ICU following sepsis compared with patients who die of nonsepsis etiologies have biochemical, flow cytometric, and immunohistochemical findings consistent with immunosuppression, and targeted immune-enhancing therapy may be a valid approach in selected patients with sepsi.
Related Papers (5)